| Property | Value |
|---|
|
?:abstract
|
-
COVID-19 caused by the SARS-CoV-2, became pandemic very quickly. Management of severe dermatologic disorders in patients who require systemic immunosuppressive treatment is a major concern in COVID-19 pandemic era. Here we report a 45-year-old homeless addicted male with second flare of severe psoriatic erythroderma and positive PCR test for COVID 19. His first attack occurred two months earlier, when he was treated and relatively controlled with cyclosporine. He discontinued all his treatment after discharged. At the time of his first admission he had been screened for COVID 19; however, all examination were negative.During this period, he not only became SARS-CoV-2 positive but also discontinued his medication. It seems that both factors could be important in flare of his erythroderma.
|
|
?:creator
|
|
|
?:doi
|
|
|
?:doi
|
-
10.1080/09546634.2020.1799918
|
|
?:journal
|
-
The_Journal_of_dermatological_treatment
|
|
?:license
|
|
|
?:pmid
|
|
|
?:pmid
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
?:source
|
|
|
?:title
|
-
A case of severe psoriatic erythroderma with COVID-19.
|
|
?:type
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}